Tazolol

Tazolol
Clinical data
ATC code	none;
Identifiers
CAS Number	39832-48-9;
PubChem CID	71721;
ChemSpider	64770;
UNII	B64Q38TX4G;
CompTox Dashboard (EPA)	DTXSID80865972 ;
Chemical and physical data
Formula	C9H16N2O2S
Molar mass	216.30 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)NCC(COC1=NC=CS1)O;

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Tazolol is a beta blocker with some utility in the treatment of heart disease.^[1]

References

^ Strosberg AM (August 1976). "The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant". Archives Internationales de Pharmacodynamie et de Therapie. 222 (2): 200–15. PMID 010864.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

[1] Strosberg AM (August 1976). "The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant". Archives Internationales de Pharmacodynamie et de Therapie. 222 (2): 200–15. PMID 010864.

[1]

See also

References